Canada Spends Logo

Explore our Budget 2026 analysis

Grant: Planning Grants-Priority Announcement:Partnerships for Health System Improvement

University of British Columbia

$24,666.00

Planning Meeting for Developing a Canadian framework for reimbursement decision-making for expensive drugs for rare diseases

FY 2011-12

Summary
Approximately 1 in 12 Canadians suffers from 1 of more than 7,000 different rare diseases, and an estimated 250 new rare diseases are being discovered every year. Treatment of these disease can cost more than $500,00 per patient per year, every year. Thus, Canada needs a framework for priority setting and decision-making specifically for expensive drugs for rare diseases, given the growing demand for new treatments, limited budgets, and competing demands on limited resources. We have compiled a group of internationally recognized researchers with expertise in health economics, health technology assessment, health policy, ethics, and law, along with proven knowledge users, all with experience in priority-setting and policy making for the treatment of rare diseases. The overarching objectives of our proposed research are to create a priority-setting and decision making framework for expensive drugs for rare diseases. The specific objective of this grant is to support the planning of our research agenda by bringing together all co-investigators and knowledge users in April/May 2012 at the University of British Columbia in Vancouver during which we will: develop and prioritize our specific research objectives; draft grant application outlines for the prioritized projects and identify project leaders; develop specific methods to address each of the priority research questions; establish a research program timeline, with both short and long term research goals; and identify specific funding opportunities beyond CIHR to support the specific research projects identified. The specific output/product of this planning meeting will be the submission of at least one collaborative operating grant application to the Fall 2012 CIHR competition, and to identify other potential tri-council and non-tri-council funding sources as as sources of research project/ operating grant funding, and submit subsequent applications to these other funding agencies.
Program
Planning Grants-Priority Announcement:Partnerships for Health System Improvement
Location
British Columbia, Canada
Recipient Type
Academia
Type
Grant
Source
CIHR Funding Decisions Database

As published

Id
246247
Name
Lynd Larry D
Region
British Columbia
Country
Canada
Orgtype
Institution Paid; Research Institution
Instname2
Health Services and Policy Research
Theme2
Health systems / services
Prcname2
Planning Grants
Projecttitle
Planning Meeting for Developing a Canadian framework for reimbursement decision-making for expensive drugs for rare diseases
Programtype2
Miscellaneous Programs
Orgnameinp2
University of British Columbia
Cihramount2
$24,666
Cihrequipment2
$0
Programname2
Planning Grants-Priority Announcement:Partnerships for Health System Improvement
Keyworddelim
Decision-Making; Innovation; Planning Meeting; Rare Diseases; Societal Value
Abstract
Approximately 1 in 12 Canadians suffers from 1 of more than 7,000 different rare diseases, and an estimated 250 new rare diseases are being discovered every year. Treatment of these disease can cost more than $500,00 per patient per year, every year. Thus, Canada needs a framework for priority setting and decision-making specifically for expensive drugs for rare diseases, given the growing demand for new treatments, limited budgets, and competing demands on limited resources. We have compiled a group of internationally recognized researchers with expertise in health economics, health technology assessment, health policy, ethics, and law, along with proven knowledge users, all with experience in priority-setting and policy making for the treatment of rare diseases. The overarching objectives of our proposed research are to create a priority-setting and decision making framework for expensive drugs for rare diseases. The specific objective of this grant is to support the planning of our research agenda by bringing together all co-investigators and knowledge users in April/May 2012 at the University of British Columbia in Vancouver during which we will: develop and prioritize our specific research objectives; draft grant application outlines for the prioritized projects and identify project leaders; develop specific methods to address each of the priority research questions; establish a research program timeline, with both short and long term research goals; and identify specific funding opportunities beyond CIHR to support the specific research projects identified. The specific output/product of this planning meeting will be the submission of at least one collaborative operating grant application to the Fall 2012 CIHR competition, and to identify other potential tri-council and non-tri-council funding sources as as sources of research project/ operating grant funding, and submit subsequent applications to these other funding agencies.
Competitiondate
201110
Approvedterm2
1 yr 0 mth
Pinamesdelim
Lynd, Larry D
Approvedterm
1 an 0 mois
Cihrcontribution2
~ $24,666~ $0~